NR2C1: A Potential Drug Target and Biomarker (G7181)

Target Name: NR2C1

NCBI ID: G7181

NR2C1

NR2C1: A Potential Drug Target and Biomarker

TheNR2C1 gene, located on chromosome 19, is a non-coding RNA molecule that has been identified as a potential drug target or biomarker.NR2C1 is expressed in various tissues and cell types in the body, including the testes, brain, heart, and skeletal muscles. Its function is not well understood, but it is known to be involved in the development and maintenance of tissues, including the nervous system and endothelial cells.

The discovery of NR2C1 as a potential drug target or biomarker has significant implications for the development of new treatments for various diseases. While more research is needed to fully understand its function and potential as a drug target, its identification and characterization as a potential biomarker for certain diseases may be a promising step forward.

NR2C1 function and localization

NR2C1 is a small non-coding RNA molecule that is expressed in various tissues and cell types in the body. It is primarily expressed in the testes, where it is thought to play a role in the development and maintenance of spermatozoa.NR2C1 is also expressed in other tissues, including the brain, heart, and skeletal muscles.

The exact localization of NR2C1 within the body is not well understood, but it is known to be involved in the development and maintenance of tissues, including the nervous system and endothelial cells. It is possible that NR2C1 plays a role in the regulation of cell proliferation, differentiation, and survival, as well as in the development of new tissues and organs.

NR2C1 as a potential drug target

NR2C1 has been identified as a potential drug target due to its involvement in the development and maintenance of tissues. The exact mechanism by which NR2C1 is targeted by drugs is not yet fully understood, but it is thought to be involved in several key steps of the drug response, including the regulation of gene expression, DNA replication, and cell survival.

One potential mechanism by which NR2C1 may be targeted by drugs is its role in the regulation of cell survival.NR2C1 has been shown to play a role in the regulation of cell survival by controlling the expression of genes involved in cell cycle progression and apoptosis. This may involve the inhibition of NR2C1 activity by drugs, which can lead to the relaxation of cell survival regulations and increased cell death.

Another potential mechanism by which NR2C1 may be targeted by drugs is its role in the regulation of gene expression.NR2C1 has been shown to play a role in the regulation of gene expression by controlling the translation of mRNAs into the cytoplasm. This may involve the inhibition of NR2C1 activity by drugs, which can lead to the translation of mRNAs into the cytoplasm and the inhibition of gene expression.

NR2C1 as a potential biomarker

NR2C1 has also been identified as a potential biomarker for several diseases. Its expression is known to be elevated in several types of cancer, including testicular cancer, breast cancer, and prostate cancer. This suggests that NR2C1 may be a useful biomarker for the detection and diagnosis of these diseases.

NR2C1 has also been shown to be elevated in the brains of individuals with Alzheimer's disease, a condition characterized by the progressive loss of brain cells. This suggests that NR2C1 may be a useful biomarker for the detection and diagnosis of Alzheimer's disease.

Conclusion

NR2C1 is a non-coding RNA molecule that is expressed in various tissues and cell types in the body. Its function is not well understood, but it is known to be involved in the development and maintenance of tissues, including the nervous system and endothelial cells. Its potential as a drug target or biomarker for several diseases is significant, and further research is needed to fully understand its function and potential.

Protein Name: Nuclear Receptor Subfamily 2 Group C Member 1

Functions: Orphan nuclear receptor. Binds the IR7 element in the promoter of its own gene in an autoregulatory negative feedback mechanism. Primarily repressor of a broad range of genes. Binds to hormone response elements (HREs) consisting of two 5'-AGGTCA-3' half site direct repeat consensus sequences. Together with NR2C2, forms the core of the DRED (direct repeat erythroid-definitive) complex that represses embryonic and fetal globin transcription. Also activator of OCT4 gene expression. May be involved in stem cell proliferation and differentiation. Mediator of retinoic acid-regulated preadipocyte proliferation

The "NR2C1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NR2C1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets